OSAGY yields 1.64% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, OSAGY + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of OSAGY + PFE for your $10,000?
OSRAM Licht AG provides various lighting products and solutions worldwide. The company operates through three segments: Opto Semiconductors, Automotive, and Digital. It manufactures light-emitting diodes (LEDs) that are used in general lighting, automotive, consumer, and industrial applications; and infrared, laser, and optical sensors for the automotive, smartphone, wearable, general lighting, industrial lighting, and projection sectors, as well as lightings for plants. The company also develops and produces lamps and lighting systems for stages, cinemas, and studios; LED-based plant cultivation systems; lighting solutions for industrial and medical applications, such as high-intensity UV lamps and LED illumination for clothing; and automotive systems based on LED and laser technology, and other customer-specific system solutions. In addition, it develops, produces, and markets LED light engines and light management systems, as well as electronic ballasts, LED drivers, and LED modules. Further, the company is involved in the provision of products in the areas of architectural interior and exterior lighting, as well as professional interior lighting solutions. It provides its products under the OSRAM, Vixar, SYLVANIA, Traxon, e:cue, Digital Lumens, Fluence, Clay Paky, ADB Stagelight, OSRAM CONTINENTAL, LED Engin, and b,a,g, brands. The company was formerly known as Kyros A AG and changed its name to OSRAM Licht AG in November 2012. The company was founded in 1906 and is headquartered in Munich, Germany. OSRAM Licht AG operates as a subsidiary of ams AG.
Full OSAGY Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.